📖
MicroRNA and Cancer
DOAB Contributor

MicroRNA and Cancer

Author / Organization:
Open Access Books Published 2022 Verification Pending

Overview & Synopsis

MicroRNAs (miRs) are small noncoding RNAs that function as post-transcriptional regulators of gene expression and have important roles in almost all biological pathways. Deregulated miR expression has been detected in numerous cancers, where miRs act as both oncogene and tumor suppressors. Due to their important roles in tumorigenesis, miRs have been investigated as prognostic and diagnostic biomarkers and as useful targets for therapeutic intervention. From a therapeutic point of view, two modalities can serve to rectify gene networks in cancer cells. For oncomiRs, a rational means is downregulation through antagomirs. Moreover, observations of the pathological reductions in tumor-suppressive miRs have inspired the concept of “miR replacement therapy” to enhance the amount of these miRs, thereby restoring them to normal levels. However, the clinical applicability of miR-based therapies is severely limited by the lack of effective delivery systems. Therefore, to understand the role of this new class of regulators, we need to identify the mRNA targets regulated by individual miRs as well as to develop specific, efficient, and safe delivery systems for therapeutic miRs.

Indexed from repository: Directory of Open Access Books (www.doabooks.org)

Document Information

Document Title MicroRNA and Cancer
Author / Organization DOAB Contributor
Subject & Discipline Breast cancer
Categories Open Access Books
Publication Year 2022
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website Directory of Open Access Books (www.doabooks.org)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-273289
Original Source Link Visit Source Page on www.doabooks.org »